DURECT Prices 14M Share Offering at $0.90/Share

DURECT Corporation

today announced the pricing of an underwritten public offering of 14 million shares of its common stock, offered at a price of $0.90 per share to the public.  The gross proceeds to DURECT from this offering are expected to be approximately $12.6 million, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by DURECT.  All of the shares in the offering are to be sold by DURECT.  The offering is expected to close on or about December 11, 2012, subject to the satisfaction of customary closing conditions.   (Photo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) Stifel Nicolaus Weisel is acting as sole book-running manager for the proposed offering.  A shelf registration statement on Form S-3 relating to the public offering of the shares of common stock described above was filed with the Securities and Exchange Commission (the "SEC") and is effective.  A final prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC's web site at www.sec.gov.  When available, copies of the final prospectus supplement may also be obtained from Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, California